Ayu Health receives additional funding of $5 million, storms into Hyderabad market

Ayu Health Hospitals, a fast-growing healthcare start-up with a network of 100+ hospitals across India, announced its maiden entry into Hyderabad. With the aim of providing healthcare for all, the company will be adding more hospitals to its...

Manipal Hospitals partners with Google Cloud uses Amwell to transform patient experience

Manipal Hospitals and Google Cloud have partnered ship to support the former to improve patient care, clinician experiences, and improve the hospital chain’s network efficiency...

Sun Pharma inks licensing pact with SPARC to commercialise medication in US market

Drug major Sun Pharma on said it has inked a licensing agreement with Sun Pharma Advanced Research Company to commercialise a medication for the treatment of neonatal seizures in the US market...

Lupin gets USFDA approval to market generic antibiotic drug in US

Drug firm Lupin on said it has received approval from the US health regulator to market Doxycycline Capsules used to treat bacterial infections in the American market...

Zydus Lifesciences gets USFDA Approval for generic hypertension drug

Zydus Lifesciences on said it has received nod from the US health regulator to market blood pressure lowering drug Bisoprolol Fumarate and Hydrochlorothiazide tablets in the American market. The company has received approval from the US Food and...

Clinikk organizes Evidence Based Care Pathways workshop for primary care

Clinikk, a Bengaluru based health-tech start-up, is working to develop Evidence Based Care Pathways (EBCP) for its doctors. In this regard, the company held a workshop to ensure quality healthcare and reduce clinical errors by converting...

Novartis adds 50 mln euros to European antibiotics investment budget

Sandoz, the generic drugs business that will be spun off its parent Novartis, will increase investment in its European antibiotics production network by 50 million euros ($50 million) on strong global demand for bacteria-fighting medicines....

Dr Reddy's Labs lines up Rs 1,500 cr capex with focus on biosimilars, injectables

Dr Reddy's Laboratories has earmarked a capex of around Rs 1,500 crore for FY23 with major part of it slated to go into building capacities for its biosimilar and injectable businesses, according to CFO Parag Agarwal. The Hyderabad-based drug...

India's Cipla beats estimates with 11% rise in quarterly profit

Indian drugmaker Cipla Ltd reported a bigger-than-expected 11% increase in second-quarter profit on Friday, helped by rising demand for its drugs and inhalers and a boost in its new ventures...

Pfizer-BioNTech to test combined Covid and flu vaccine

Pfizer-BioNTech said Pfizer-BioNTech to test combined Covid and flu vaccinethey will test a combined coronavirus and influenza vaccine, which could potentially pave the way for better inoculation uptake for both illnesses...

© 2025 India Pharma Outlook. All Rights Reserved.